SKLZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SKLZ is not a good buy right now for an impatient investor. The stock is in a clear downtrend (bearish moving averages and weakening MACD), and while it’s technically oversold (RSI~19) and could bounce, there is no Intellectia buy signal (AI Stock Picker/SwingMax) and no near-term news catalyst to justify stepping in immediately. I would avoid initiating a new position here until price regains key resistance (around the 4.13 pivot) or momentum indicators stabilize.
Trend/structure: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downside pressure. Momentum: MACD histogram is negative (-0.011) and expanding lower, suggesting downside momentum is still building rather than bottoming. Mean-reversion setup: RSI_6 at ~19.6 is deeply oversold, which can support a short-term bounce, but oversold alone is not a timing signal while MACD is still deteriorating. Key levels: Price 3.625 is below S1 (3.76) and near S2 (3.529), meaning support is close but already being tested. Upside resistance sits at Pivot 4.135, then R1 4.509. Market context: S&P 500 is slightly down (-0.2%), not a risk-on tailwind.
Intellectia Proprietary Trading Signals
near support (3.529–3.
can trigger short-term mean reversion.
Downtrend is intact: Bearish MA stack and a negatively expanding MACD histogram indicate momentum is still worsening.
No near-term catalyst from headlines: No news in the recent week to spark a regime change in sentiment.
Profitability deterioration: 2025/Q3 net income fell to -17.442M (worse YoY) and EPS declined to -1.14, showing continued losses despite revenue growth.
No supportive smart-money signal: Hedge fund and insider trends are neutral (no notable accumulation signal).
Latest quarter: 2025/Q3. Growth: Revenue rose to $27.374M (+11.44% YoY), and gross margin improved to 87.74% (+1.70% YoY), which is constructive for the underlying unit economics. Profitability: Net income worsened to -$17.442M (down -17.40% YoY) and EPS slipped to -1.14 (down -5.00% YoY), indicating the company is still moving further from profitability despite top-line growth.
No analyst rating or price target change data was provided, so a recent trend summary cannot be confirmed from this dataset. Wall Street-style pros (based on provided fundamentals): improving revenue growth and very high gross margin. Wall Street-style cons: ongoing and worsening net losses/EPS and a strongly bearish technical trend, which typically keeps ratings cautious until a clearer turnaround is visible. Influential/political activity: No recent congress trading data available; no politician activity indicated.
